Press Releases

Three major Pharmaceutical Benefit Managers (PBMs) confirmed that lower list prices would make the blockbuster drugs more widely available WASHINGTON, Sept. 24 – Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released a new report uncovering how Novo Nordisk, as one health insurance plan described it, is using its “position of power”

BURLINGTON, Vt., Sept. 20 — Sen. Bernie Sanders (I-Vt.), the Vermont State Dental Society (VSDS), University of Detroit Mercy (UDM), and Sen. Peter Welch (D-Vt.) today announced their historic effort to establish an innovative, new dental clinic and training program in Vermont. Through a VSDS-University of Detroit Mercy partnership, the initiative will bring UDM students to Vermont to complete their

WASHINGTON, Sept. 20 – As millions of Americans struggle with diabetes and obesity, Sen. Bernie Sanders (I-Vt.), Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), on Tuesday will lead the committee in a hearing to examine why Novo Nordisk charges the American people the highest prices in the world for its lifesaving drugs, Ozempic and Wegovy.

WASHINGTON, Sept. 19 – In a major bipartisan vote, the Senate Committee on Health, Education, Labor, and Pensions (HELP) today held Steward Health Care CEO Dr. Ralph de la Torre in civil and criminal contempt for his failure to comply with the committee’s subpoena and absence from last week’s hearing.  This is the first time in modern American history that the HELP

WASHINGTON, Sept. 19 – In a major bipartisan vote, the Senate Committee on Health, Education, Labor, and Pensions (HELP) today held Steward Health Care CEO Dr. Ralph de la Torre in civil and criminal contempt for his failure to comply with the committee’s subpoena and absence from last week’s hearing. This is the first time in modern American history that the HELP

WASHINGTON, Sept. 18 — Sen. Bernie Sanders (I-Vt.) delivered a speech on the floor of the United States Senate to discuss his intention to next week file Joint Resolutions of Disapproval (JRD) that would block the sale of more than $20 billion in offensive U.S. weaponry to Israel. The JRD is the only mechanism available to Congress to prevent an arms